Isaac Barchas

Isaac Barchas was the founder of Eradivir, Inc., founded in 2020, where the title held was Director.
Mr. Barchas is also the founder of MorphImmune, Inc...
Mr. Barchas is currently Lead Independent Director at Immunome, Inc. since 2023.
Mr. Barchas is Director at Pecan Street, Inc. Mr. Barchas is Director at Novosteo, Inc. Mr. Barchas is Managing Director at Arsenal Bridge Venture II LLC.
Mr. Barchas is Managing Director at Rbp Catalyst Fund 1.
Mr. Barchas is Director at Tetricus, Inc. Mr. Barchas is Founding Partner at Arsenal Bridge Ventures.
Formerly, Mr. Barchas was President & Chief Executive Officer at Research Bridge Partners from 2017 to 2024.
Mr. Barchas was Independent Director at Sustainable Opportunities Acquisition Corp.
from 2020 to 2021.
Mr. Barchas was Director at Austin Technology Incubator from 2006 to 2016.
Mr. Barchas was Board member at The Austin Chamber of Commerce from 2007 to 2009.
Education includes an undergraduate degree from Stanford University conferred in 1989, and graduate and doctorate degrees from The University of Chicago conferred in 1993.